journal article·2025-08Open access

A microsphere loaded with chondrocyte-targeting exosomes continuously deliver miR-148a for osteoarthritis therapy

Tao Yang, Haiwei Ma, Kechi Li, Jie Xiang, Jianxin Qiu, Yiming Ding, Chengdi Wang, Hehuan Lai, Xingyu Hu, Shijie Liu, Chao Lou, Zhenhua Hong, Zhenzhong Chen, Dengwei He

Abstract

Due to the complex pathogenesis and limited treatment options, the clinical diagnosis and treatment of osteoarthritis (OA) remains extremely challenging. Umbilical cord derived mesenchymal stem cell-derived exosomes have low immunogenicity, high biocompatibility and superior transbiofilm properties, showing great research value in OA treatment. Healthy chondrocytic extracellular matrix anabolism is essential for cartilage homeostasis. The abnormal reduction of miR-148a in chondrocytes impairs extracellular matrix anabolism, accelerating the progression of OA. Therefore, increasing miR-148a in chondrocytes is a potential OA treatment strategy. However, the dense extracellular matrix in articular cartilage hinders the delivery of exosomes and microRNAs, in addition to their short retention time in vivo greatly limits their clinical application. Herein, a biodegradable microsphere loaded with chondrocyte targeting exosomes (CAP-EXOs/miR-148a@GAM) was developed for sustained delivery of miR-148a. Firstly, we synthesized microspheres (GAM) with methacrylated gelatin and streptavidin by microfluidic system, and then loaded miR-148a into exosomes modified with chondro-targeting peptide CAP (CAP-EXOs) and encapsulated it into GAM to obtain CAP-EXOs/miR148a@GAM. The in-vitro results show that this microsphere promotes the anabolism of chondrocytes and exhibits satisfactory performance in maintaining cartilage homeostasis. The in-vivo experiments show that the microspheres can effectively delay the degeneration of osteoarthritic cartilage. Collectively, this study presents a multifunctional paradigm of nucleic acid drug delivery for the treatment of OA.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (71)

Show source-provided references
2. The global burden of osteoarthritis: past and future perspectives10.1016/S2665-9913(23)00207-2 ↗
3. Evaluation and treatment of knee pain: a review10.1001/jama.2023.19675 ↗
4. Age-associated changes in knee osteoarthritis, pain-related behaviors, and dorsal root ganglia immunophenotyping of male and female mice10.1002/art.42530 ↗
5. The structure and function of the pericellular matrix of articular cartilage10.1016/j.matbio.2014.08.009 ↗
6. Undenatured type II collagen and its role in improving osteoarthritis10.1016/j.arr.2023.102080 ↗
7. Intra-articular mineralization on computerized tomography of the knee and risk of cartilage damage: the multicenter osteoarthritis study10.1002/art.42832 ↗
8. Piezo1 activation accelerates osteoarthritis progression and the targeted therapy effect of artemisinin10.1016/j.jare.2023.09.040 ↗
9. Nitisinone attenuates cartilage degeneration and subchondral osteoclastogenesis in osteoarthritis and concomitantly inhibits the cGAS/STING/NF-κB pathway10.1016/j.ejphar.2024.176326 ↗
10. Mechanical stress abnormalities promote chondrocyte senescence - the pathogenesis of knee osteoarthritis10.1016/j.biopha.2023.115552 ↗
11. PDZK1 protects against mechanical overload-induced chondrocyte senescence and osteoarthritis by targeting mitochondrial function10.1038/s41413-024-00344-6 ↗
12. MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis
13. Hypoxia and matrix metalloproteinase 13-responsive hydrogel microspheres alleviate osteoarthritis progression in vivo
14. Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in Osteoarthritis10.1186/s12951-023-02086-9 ↗
15. MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP110.1038/s41420-022-01261-5 ↗
16. Overexpression of miR-148a-3p inhibits extracellular matrix degradation and alleviates IL-1β-induced intervertebral disc degeneration
17. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes10.1016/j.joca.2013.11.006 ↗
18. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application10.1038/nrd3010 ↗
19. Emerging concepts of miRNA therapeutics: from cells to clinic10.1016/j.tig.2022.02.006 ↗
20. Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR10.1016/j.addr.2014.05.002 ↗
21. Living cell nanoporation and exosomal RNA analysis platform for real-time assessment of cellular therapies10.1021/jacs.2c02268 ↗
22. MicroRNA-200 loaded lipid nanoparticles promote intestinal epithelium regeneration in canonical MicroRNA-deficient mice10.1021/acsnano.3c08030 ↗
23. Agomir-122-loaded nanoparticles coated with cell membrane of activated fibroblasts to treat frozen shoulder based on homologous targeting10.1186/s12951-024-02403-w ↗
24. Agomirs upregulating carboxypeptidase E expression rescue hippocampal neurogenesis and memory deficits in Alzheimer's disease10.1186/s40035-024-00414-z ↗
25. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment10.7150/thno.69368 ↗
26. A tetrahedral framework DNA-based bioswitchable miRNA inhibitor delivery system: application to skin anti-aging10.1002/adma.202204287 ↗
27. MicroRNA delivery systems in glioma therapy and perspectives: a systematic review10.1016/j.jconrel.2022.07.027 ↗
28. MicroRNA delivery for regenerative medicine10.1016/j.addr.2015.05.014 ↗
29. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
30. Umbilical cord MSCs and their secretome in the therapy of arthritic diseases: a research and industrial perspective10.3390/cells9061343 ↗
31. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases10.3389/fimmu.2021.749192 ↗
32. Clinical applications of stem cell-derived exosomes10.1038/s41392-023-01704-0 ↗
33. Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing10.1186/s12951-023-01778-6 ↗
34. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications10.1016/j.jconrel.2022.12.027 ↗
35. Chondrocyte-targeted MicroRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy10.1021/acsami.0c10458 ↗
36. Engineering exosomes for targeted drug delivery10.7150/thno.52570 ↗
37. Cell-free osteoarthritis treatment with sustained-release of chondrocyte-targeting exosomes from umbilical cord-derived mesenchymal stem cells to rejuvenate aging chondrocytes10.1021/acsnano.3c01612 ↗
38. Exosome theranostics: biology and translational medicine10.7150/thno.21945 ↗
39. GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing10.1186/s12951-022-01354-4 ↗
40. Human urine-derived stem cell exosomes delivered via injectable GelMA templated hydrogel accelerate bone regeneration
41. Ball-bearing-Inspired polyampholyte-modified microspheres as bio-lubricants attenuate osteoarthritis
42. Biomimetic injectable hydrogel microspheres with enhanced lubrication and controllable drug release for the treatment of osteoarthritis
43. Snail-inspired AFG/GelMA hydrogel accelerates diabetic wound healing via inflammatory cytokines suppression and macrophage polarization10.1016/j.biomaterials.2023.122141 ↗
44. NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice10.1186/s12974-020-01787-4 ↗
45. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches10.1002/jev2.12404 ↗
46. Exosomes are natural carriers of exogenous siRNA to human cells in vitro10.1186/1478-811X-11-88 ↗
47. Chondrocyte-targeted delivery system of Sortase A-engineered extracellular vesicles silencing MMP13 for osteoarthritis therapy10.1002/adhm.202303510 ↗
48. Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration10.1016/j.jconrel.2024.04.009 ↗
49. Biotin-avidin system-based delivery enhances the therapeutic performance of MSC-derived exosomes10.1021/acsnano.3c00839 ↗
50. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis10.1016/j.joca.2019.06.011 ↗
51. Methods of conservative intra-articular treatment for osteoarthritis of the hip and knee
52. Arthroscopic surgery for degenerative knee disease (osteoarthritis including degenerative meniscal tears)
53. Association between surgical approach and major surgical complications in patients undergoing total hip arthroplasty10.1001/jama.2020.0785 ↗
54. Current understanding of osteoarthritis pathogenesis and relevant new approaches10.1038/s41413-022-00226-9 ↗
55. Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation10.1186/s12920-023-01597-6 ↗
56. Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis10.1136/ard-2022-223789 ↗
57. microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints10.1136/annrheumdis-2018-213629 ↗
58. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K910.1038/s41401-022-00893-8 ↗
59. CircRNA 0009043 suppresses non-small-cell lung cancer development via targeting the miR-148a-3p/DNAJB4 axis10.1186/s40364-022-00407-y ↗
60. Role of slit/robo signaling pathway in bone metabolism10.7150/ijbs.66931 ↗
61. Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signaling10.1002/hep.32140 ↗
62. SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia10.1172/JCI141083 ↗
63. Type H blood vessels in bone modeling and remodeling10.7150/thno.34126 ↗
64. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression10.1126/sciadv.abo7868 ↗
65. Antioxidant PDA-PEG nanoparticles alleviate early osteoarthritis by inhibiting osteoclastogenesis and angiogenesis in subchondral bone10.1186/s12951-022-01697-y ↗
66. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis10.1038/nrrheum.2012.80 ↗
67. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development10.1172/jci.insight.135446 ↗
68. Evolutionary conserved circular MEF2A RNAs regulate myogenic differentiation and skeletal muscle development10.1371/journal.pgen.1010923 ↗
69. ROBO2 signaling in lung development regulates SOX2/SOX9 balance, branching morphogenesis and is dysregulated in nitrofen-induced congenital diaphragmatic hernia10.1186/s12931-020-01568-w ↗
70. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: promises, problems and prospects10.1002/med.22002 ↗
71. Exosome lncRNA IFNG-AS1 derived from mesenchymal stem cells of human adipose ameliorates neurogenesis and ASD-like behavior in BTBR mice10.1186/s12951-024-02338-2 ↗